Objectives: As a long-acting DPP-4 inhibitor administered orally once a week, trelagliptin can address the issues of frequent medication and poor compliance associated with traditional hypoglycemic drugs. Revealing the pharmacokinetic changes of trelagliptin ... ...

请注册登录后继续浏览